United States· US:82228-712_28373fa9-eaed-4941-9b38-89ebe785c2d6

Attruby

A acoramidis product containing acoramidis hydrochloride, registered in United States by BridgeBio Pharma, Inc.. The same ATC class is registered in 14 of our 19 countries.

ATC C01EB25US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAttrubyATCC01EB25REGISTER NO.US:82228-712_28373fa9…PACKS LISTED2CHECKEDJune 26, 2026

Where it is registered

Acoramidis is registered in 14 of 19 countries.

Countries holding a registration under ATC C01EB25 (acoramidis), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Acoramidis · ATC C01EB25

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acoramidis costs, country by country.

Normalised to the WHO defined daily dose (1.424 g), the median price runs from $0.17 in France to $300.19 in Switzerland — a ×1790 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Acoramidis · price per daily dose (1.424 g)

USD · FX 28 Sept 2026

  • CH Switzerland$300.19
  • FR France$0.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ACORAMIDIS HYDROCHLORIDE
Manufacturer
BridgeBio Pharma, Inc.
Country
United States (US)
ATC code
C01EB25
ATC class
Acoramidis
Defined daily dose
1.424 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 26, 2026

Packs & prices · 2

  • ndc11
    8222871228
    4 DOSE PACK in 1 CARTON (82228-712-28) / 1 BLISTER PACK in 1 DOSE PACK / 28 TABLET, FILM COATED in 1 BLISTER PACK
  • ndc11
    82228-712-28

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Acoramidis in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acoramidis products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Beyonttra
  • Liechtenstein · Beyonttra
  • Norway · Beyonttra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/89b86366-03e7-442e-82aa-18e89d2acf24
GET /v1/drugs/89b86366-03e7-442e-82aa-18e89d2acf24?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "356",
  "substance": "ACORAMIDIS HYDROCHLORIDE",
  "productndc": "82228-712",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA216540",
  "marketing_category": "NDA"
}

See everything about acoramidis.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.